Our Partners
We thank our Corporate Partners for helping us develop and apply research to improve newborn and child health.
 |
Aguettant is a family-owned pharmaceutical company dedicated to the development, industrial production and distribution of innovative injectable pharmaceutical specialties that meet the demands and the needs of healthcare professionals and patients. Founded in Lyon, France in 1903, Laboratoire Aguettant's growth has been rooted in its engagement with the medical world and its pharmaceutical expertise in injectable medication. |
 |
AstraZeneca is a global, science-led, patient-focused pharmaceutical company. It is focused on creating genuinely innovative medicines and improving access to them. Inspired by its Values and what science can do, AstraZeneca is focused on accelerating the delivery of life-changing medicines that create enduring value for patients and society. |
 |
Gennisium Pharma is a privately owned company, created by individuals with diverse experience in the pharmaceutical industry, and notably, in the development and marketing of treatments for rare metabolism disorders, paediatric formulations and Orphan drugs. It aims to manage key and strategic functions in house, in particular Regulatory Affairs, Medical and Marketing as well as Commercialisation of drugs, with its own sales force, in key European and export countries. |
 |
Medela turns science into care while nurturing health for generations, through advancing research, observing natural behavior and listening to its customers. Medela supports millions of moms, babies, patients and healthcare professionals in more than 100 countries all over the world. As the healthcare choice for more than 6 million hospitals and homes across the globe, Medela is dedicated to developing innovations that build better outcomes, providing the leading research-based breast milk feeding and baby products, healthcare solutions for hospitals, and clinical education. |
The ESPR is supported by unrestricted grants from our corporate partners. Partner organisations do not influence ESPR policy, content, or programming.
How to partner with the ESPR
Support us in improving newborn and child health.
The ESPR aspires to form strong, mutually-beneficial alliances with its partners towards developing and applying research to improve newborn and child health. We offer a broad range of opportunities to engage and collaborate with our society and support our network of peers and experts in paediatric medical care and innovation. Currently, there are several fields of activity that allow for a tailored partnership:
- Our annual meetings - the European Academy of Paediatric Societies Congresses (EAPS) & the Congress of joint European Neonatal Societies (jENS);
- The society awards: the ESPR Early Career Investigator Awards, the Bengt Robertson Award, the Congress Travel Grants.
- The grant programmes dedicated to Paediatric research and innovation: the large-scale Research Grant Programme, the University of Oxford MSc in Clinical Trials Scholarship, the Roland R. Wauer Award;
- The European School of Neonatology (ESN): the Master in Advanced Studies (MAS), the ESN free lecture series 'Perspectives on Effective Neonatology' and the ESN Special Courses and Training;
- Our mentoring programme dedicated to Early Career Investigators(ECIMP);
- Our academic journal Pediatric Research co-owned with our US-based sister societies the Society for Paediatric Research (SPR) and the American Paediatric Society (APS).
If you are interested to become a partner of our society or require further information, please send us a message via the contact form below. We would be happy to support you in finding a suitable solution reagarding the scope and type of our partnership.
